UniCredit Bank GmbH Share Price

Certificat

DE000HD453X2

Market Closed - BOERSE MUENCHEN 01:15:23 15/06/2024 am IST
32.02 EUR -0.50% Intraday chart for UniCredit Bank GmbH
Current month+0.31%
1 month+1.62%
Date Price Change
14/24/14 32.02 -0.50%
13/24/13 32.18 -0.37%
12/24/12 32.3 +0.12%
11/24/11 32.26 -0.12%
10/24/10 32.3 0.00%

Real-time BOERSE MUENCHEN

Last update June 15, 2024 at 01:15 am IST

More quotes

Static data

Product typeDiscount Certificates
Buy / SellCALL
Underlying ECKERT & ZIEGLER SE
IssuerLogo Issuer UniCredit UniCredit
WKN HD453X
ISINDE000HD453X2
Date issued 26/03/2024
Maturity 21/03/2025 (278 Days)
Parity 1 : 1
Emission price 30.2
Emission volume N/A
Settlement both
Currency EUR

Technical Indicators

Highest since issue 32.9
Lowest since issue 28.4

Company Profile

Eckert & Ziegler SE is a Germany-based Company, which is a provider of isotope technology for medical, scientific and industrial use with focus on cancer therapy, industrial radiometry and nuclear-medical imaging. The Company operates through three segments: Radiation Therapy, Isotope Products and Radiopharma. The Radiation Therapy segment operates through Eckert & Ziegler BEBIG and produces and distributes medical products for the treatment of cancer using brachytherapy. The Isotope Products segment provides sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration and environmental monitoring sources and solutions, as well as bulk radioisotopes for pharmaceutical, therapeutic and industrial product manufacturers. The Radiopharma segment specializes in molecular imaging and nuclear medicine, and supplies various radiopharmaceuticals, radiochemicals and related equipment.
Sector
-
More about the company

Ratings for Eckert & Ziegler SE

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Eckert & Ziegler SE

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
44.84 EUR
Average target price
62.5 EUR
Spread / Average Target
+39.38%
Consensus